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1. SUMMARY 
Macrolides, macrocyclic lactones containing at least a ring of twelve members, present 
many interesting features, such as antibiotic, antifungal or anticancer activities, among others. 
Isolation from natural sources often provides limited quantities of these compounds. Therefore 
there is great interest in the consecution of their total syntheses. A key step in their preparation 
is cyclization, since it is often a challenging step. The most common method to form the ring is 
macrolactonization, although, in recent years, ring-closing metathesis has also been used by 
many research groups. However, these methods are not always appropriate for all macrolides, 
depending on their size and structure. In this report, an exhaustive bibliographic search has 
been undertaken to analyze which alternative methods are being used most often to cyclize 
these compounds. SciFinder and Reaxys are the databases that have been chosen for this 
search during the period 2012 to 2017. Several methods have been identified. Apart from 
macrolatonizations and ring-closing metathesis, the most popular are cross-coupling methods 
and olefinations. The use of the most common alternatives for the total synthesis of natural 
product macrolides in the period 2012–2017 has been reviewed.  
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2. RESUM 
Els macròlids, lactones macrocícliques que contenen un mínim de dotze baules, presenten 
moltes propietats interessants, com activitats antibiòtiques, antifúngiques i anticancerígenes, 
entre d’altres. L’aïllament d’aquestes molècules de fonts naturals ens proporciona quantitats 
molt petites d’aquests compostos. Per això hi ha molt interès en les seves síntesis totals. Un 
pas clau en la seva preparació és la ciclació, ja que sovint és un pas complicat.. El mètode més 
comú per formar l’anell és la macrolactonització, tot i que, en aquests darrers anys, el 
tancament d’anell per metàtesi també ha estat usat per molts grups de recerca. Tot i això, 
aquests mètodes no són sempre adequats per molts macròlids, depenent de la seva mida i 
estructura. En aquest treball, s’ha realitzat una recerca bibliogràfica exhaustiva per trobar quins 
mètodes alternatius a la macrolactonització i la metàtesi s’empren més sovint per a la ciclació 
d’aquests compostos. Les bases de dades escollides per fer la cerca han estat SciFinder i 
Reaxys, en el període que va del 2012 al 2017. Diversos mètodes han estat identificats. A part 
de la macrolactonització i la metàtesi de tancament d’anell, els més populars són els 
acoblaments creuats i les olefinacions. S’ha revisat l’ús de cinc d’aquests mètodes per a la 
síntesi total de macròlids naturals en el període 2012–2017. 
 
Paraules clau: Macròlids, Síntesi Total, Macrociclació 
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3. INTRODUCTION 
Macrolides, macrocyclic lactones with a ring of twelve members or more,1 present a number 
of interesting properties that make them especially useful in many areas.2 For example, we can 
find macrolides with antibiotic, cytotoxic and antiangiogenesis properties, or having pheromone 
and insecticide activities. Since the first isolation of a macrolide in the 1950s, their properties 
have been investigated by many research groups, and many applications for this class of 
compounds have been found, particularly in drug discovery. For instance, Erythromycin A and 
its semi-synthetic analogs are used to treat bacterial respiratory infections, and Amphotericin B 
is a polyene antifungal drug. Other examples are Spinosyn A and D that are used against a 
wide variety of insects, and Epothilone A, an analogs of which has already been approved for 
the treatment of breast cancer (Figure 1). 
Figure 1. Examples of Macrolides. 
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Because of the minute amount of these compounds available by isolation from the natural 
sources, the total synthesis of macrolides is crucial to access enough quantities to study them 
further. Total synthesis of such complex molecules involves many steps and the order of these 
steps is important for the success of the synthesis. One of the most important steps is the 
formation of the ring, not always an easy task, although nowadays there are a wide range of 
methods available for macrocyclization, such as macrolactonization, the method traditionally 
used to construct the ring. 
Macrolactonization2 involves the reaction of a hydroxyl and a carboxylic acid group from a 
seco-acid. The activation of either the alcohol or the carboxylic acid terminal group is usually 
required to achieve the reaction (Scheme 1). Depending on the group activation, we can have 
different macrolactonization methods. Nowadays, some of the most commonly used methods in 
the synthesis of macrolides are the Yamaguchi, Shiina or Kita–Trost procedures, if the activated 
group is the acid, and the Mitsunobu protocol, if the activated group is the hydroxyl. The main 
problem that macrolactonization reactions present is the competition between intramolecular 
and intermolecular reactions. To solve this, the reaction is performed under high dilution 
conditions: the substrate is slowly added over many hours to a large volume of solvent. Another 
alternative method to avoid this situation is to immobilize the seco-acid, or an activated 
intermediate, on a solid support. 
 
Scheme 1. Cyclization by macrolactonization. 
Although macrolactonization is the typical method for the construction of a macrolide ring, in 
the last decade ring-closing metathesis3 has been used more and more. 
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Ring-closing metathesis (RCM) is a cyclization method via carbon-carbon bond formation. It 
involves the reaction of two terminal alkenes (Scheme 2). The main advantage of RCM is the 
compatibility with most functional groups. In addition, it generates a double bond in the molecule 
that can be transformed into another functional group. However, controlling the stereochemistry 
of this double bond and finding appropriate reaction conditions is not an easy task. The reaction 
needs a catalyst to guarantee its success. Although the most common catalysts are ruthenium 
complexes, highly reactive molybdenum Schrock catalysts are also used. 
Scheme 2. Cyclization by ring-closing metathesis. 
Although macrolactonization reactions and ring-closing metathesis are commonly applied to 
form the ring of complex macrolides, their implementation is not always straightforward and 
application to a particular substrate can be problematic and low-yielding. Taking into account 
that formation of the ring is usually one of the last steps of a total synthesis, this can severely 
affect its global yield. Due to our involvement in the total synthesis of several macrolides,4–8 our 
group has a long-standing interest in macrocyclization reactions in general and 
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macrolactonizations9 in particular, a reaction which we have used regularly to form the lactone 
ring of naturally-occurring macrolides synthesized in our labs. Apart from the two methods 
described previously, other macrocyclization reactions are employed in the total synthesis of 
macrolides, although to a lesser extent. Knowing which methods are available to form the ring of 
complex macrolides and their advantages and disadvantages compared to the most standard 
methodologies will help us choose the best macrocyclization strategy for a particular substrate 











Considering the interest of our research group in the total synthesis of macrolides, our main 
objective is the analysis and review of alternatives to macrolactonization and RCM for the 
formation of the ring of a macrolide. To achieve this, the following steps were taken: 
 Exhaustive review of the literature (2012–2017) using the Reaxys and SciFinder 
databases. 
 Analysis of the results and organization of the references into tables. 

















To fulfill our objective, we first searched the literature for reports on the total synthesis of 
macrolides that meet specific structural characteristics. We considered only natural-product 
macrolides and excluded cyclodepsipeptides, macrodiolides and ansa-macrolides. In addition, 
macrolides with a fused benzene ring were not taken into account. The search was made in the 
recent literature (2012–2017) and using two chemical databases: SciFinder and Reaxys.  
First, we searched using the keywords “total synthesis macrolide” on both databases. This 
search was filtered by year, journal name and type of document. Moreover, we searched by 
reaction using Scheme 3 as template on Reaxys. In that case, the filters that were applied are 
by year, type of document and number of steps. 
To follow up, the results were analyzed visually one by one to ascertain whether the 
macrolide fulfilled the desired characteristics. Because of the fact that the search was made 
twice using different strategies, some results were duplicated and it was necessary to reject 
those. Finally, a table was generated to organize the data.  
 
 
Scheme 3. Template used to search by reaction. 
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6. RESULTS AND DISCUSSION 
After searching (for the period 2012–2017) for the total synthesis of macrolides published in 
the literature (as discussed in the Methods Section), the data was organized into tables (Tables 
1-3). Tables 1 and 2 show the results of macrolactonization and RCM respectively, whereas 
Table 3 shows all the results of the alternative methods of cyclization. As observed in Figure 2, 
once the results are analyzed, we can confirm that the most used methods to cyclize the 
macrolide ring are macrolactonization, RCM and an alternative RCM method: ring-closing 
alkyne metathesis (RCAM). However, we can also conclude that coupling methods, such as the 
Stille, Heck or Suzuki couplings, are also frequently used, while methods that involve the 
formation of a double bond to close the ring, such as the Horner–Wadsworth–Emmons (HWE) 
or Wittig reactions, are less used. Finally, cyclizations using other methods are scarce. 
Figure 2. Methods of macrolide ring formation (2017–2012). 
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Figure 3 shows the number and type of cyclizations per year. As can be seen, the use of 
alternative methods has increased in the last years. However, macrolactonization and RCM 
remain the preferred methods to construct the ring of macrolides. 
Figure 3. Methods of macrolide ring formation. 
Particularly, a peak in the use of RCAM between the years 2013 and 2015 is observed. This 
can be attributed to the studies performed by Alois Fürstner, who has developed this method for 
the total synthesis of natural products. In addition, the use of cross couplings (Stille, Heck and 
Suzuki) and methods that form double bonds (Wittig and HWE) has increased in the last years. 
However, no Negishi cross coupling was found for the ring formation of macrolides, probably 
because of the difficulty of the preparation of the required organozinc compound. Another 
reaction that was not found is the Julia–Kocienski reaction, despite the fact that it is commonly 
used to form alkenes. 
Moreover, only two of the alternative methods found forms a new stereocenter: the Nozaki–
Hiyama–Kishi coupling and reactions that involve attack of an organometal to an aldehyde. 
In the next pages, we will review the most used alternative methods for macrolide ring 
formation in the period 2012–2017. In addition, whenever possible, a comparison of the different 
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Epothilones B and D54 
Ivorenolide A55 













(a) Analog or derivative synthesis 
 
  






























































Yuzu lactone, Ambrettolide 
and Epothilone C116 






























(a) Analog or derivative synthesis 
 
Table 2. Macrolides prepared by RCM in the period 2012–2017.
 






































Palmerolide A174 Kulkenon175 
Mandelalide A176 
Palmerolide A177  
Suzuki coupling   Tiacumicin B















     Laulimalide188 
Wittig 
Aspicillin189   (+)-Chloriolide190   
Castro–Stephens 
Glaser–Hay coupling 
 Ivorenolide A191 Lactimidomycin192    
Nozaki–Hiyama– 
Kishi coupling 
 Sacrolide A193   Cethromycina,194  
Organometal 
addition to an 
aldehyde 
Aplyronine A195 Borrelidin a,196   Epothilone D197  
(a) Analog or derivative synthesis      
Table 3. Macrolides prepared by other methods (2012–2017).
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6.1. MACROCYCLIZATION VIA STILLE COUPLING 
The Stille coupling198 is a palladium-catalysed cross-coupling reaction that involves the 
reaction of organostannanes and aryl or vinyl halides to form a new C–C bond. In 1976, the first 
report of the reaction was made by Eaborn and Kosugi. However, Stille and his co-workers 
transformed it into a standard method in organic synthesis. The use of the Stille coupling has 
increased in the last few years and is used more and more to construct a variety of ring 
systems.199–202 Its tolerance towards most functional groups made the Stille coupling an 
effective reaction, displaying high selectivity. 
A scheme of Stille coupling is shown in Scheme 4. An oxidative addition between Pd0 and 
the vinyl halide part in the molecule forms an intermediate species that transmetallates with the 
organostanne. Transmetallation is believed to be the slow step of the reaction, as the only 
observable species is the vinylpalladium intermediate. Later, a reductive elimination forms the 
macrolide ring. 
Scheme 4. The Stille coupling to form a macrolide. 
The total synthesis of natural products using a Stille reaction as the macrocyclization step 
has been reviewed, although the recent literature is not covered.199–202 
Truncated Superstolide A (Figure 4) was successfully synthesized using Stille coupling as 
the macrocyclization step in 2013 by Jin and his co-workers.168 Superstolides A and B were 
isolated in minute amounts from the deep-water marine sponge Neosiphonia superstes and 
exhibit a potent antiproliferative effect against several tumor cell lines. Several years ago, Jin 
initiated research towards the total synthesis of Superstolides A and B. Because of the 
structural complexity of the target molecules, it would be extremely challenging to develop a 
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practical synthesis that provides adequate amounts. Therefore they decided to develop first a 
practical total synthesis of an analog. 
Figure 4. Superstolide A, Superstolide B and truncated Superstolide A. 
Considering the drawbacks of macrolactonization in the previous studies, they used the 
Stille coupling to form the ring. The Stille macrocyclization of truncated Superstolide A was 
achieved in excellent yield (88%), using the conditions developed by Farina in 1991203 (Sheme 
5). 
Scheme 5. Cyclization step to form truncated superstolide A. 
In 2014, the research group of Suenaga achieved the first total synthesis of Biselyngbyolide 
A,166 an 18-membered marine macrolide with significant biological activities. Using a similar 
approach, they published the total synthesis of Biselyngbyolide B167 in 2016 and of 
Biselyngbyaside in 2017164 (Figure 5). 
Figure 5. Biselyngbyolide A, Biselyngbyolide B and Biselyngbyaside. 
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In all of these syntheses, they build the ring using the Stille coupling (Scheme 6). The first 
intention was to form the ring using macrolactonization, but they could not obtain the 
hydroxyacid precursor because the conjugated diene was unstable under the oxidation reaction 
conditions. In the three cases, the yield achieved was 53%, 94% and 81% respectively. 
Scheme 6. Cyclization step to obtain protected Biselyngbyolide A. 
Chivosazole F was synthesised by the Paterson research group in 2017.165 They first 
wanted to use a Horner–Wadsworth–Emmons reaction to form the C2–C3 bond of the 
macrolide. This would avoid manipulating a vulnerable (Z,E,Z,E)-tetraenoate motif. However, 
the required aldehyde could not be prepared because of the instability of the precursor. The 
researchers chose a Stille coupling as an alternative. Finally, the cyclization of Chivosazole F 
was achieved in 41% of yield (three steps) (Scheme 7). 
Scheme 7. Cyclization step to form Chivosazole F. 
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6.2. MACROCYCLIZATION VIA HECK COUPLING 
The Heck coupling204 is a palladium-catalyzed cross-coupling reaction between an aryl or 
vinyl halide with an alkene in the presence of a base which results in the formation of a C–C 
bond. The Heck coupling is also called Mizoroki–Heck reaction as the result of the 
investigations that Mizoroki and Heck made independently. However, Heck developed the 
general method that is used nowadays. Although small variations of substrates or ligands can 
change dramatically the results of the reaction, the Heck reaction is one of the most versatile 
reactions in the synthesis of natural products.  
In Scheme 8 we can see the construction of a macrolide using the Heck coupling. In most 
cases, Pd0 is prepared from palladium complexes by reduction. An oxidative addition is required 
to insert palladium in the aryl or vinyl halide bond. In the following step, the alkene coordinates 
with Pd and a migratory insertion follows. Finally, a reductive elimination forms the ring of the 
macrolide. The first Heck coupling used in the total synthesis of a macrolide was reported by 
Zeigler and co-workers in 1981 in their total synthesis of carbomycin B.205 Since then many 
research groups have used the Heck coupling as the macrocyclization step, and the recent 
literature has been reviewed.199 
Scheme 8. The Heck coupling to form a macrolide. 
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Palmerolide A was prepared by the research groups of Dudley177 and Mohapatra,174 using a 
similar Heck macrocyclization (Scheme 9). Furthermore, Palmerolide A has also been 
synthesized using RCM by Prasad in 2012.128 The cyclization yield was 62% and Grubbs 
second generation catalyst was used (Scheme 10). Scheme 11 shows the structure of 
Palmerolide A and a comparative between the different macrocyclization methods used.  
Scheme 9. Cyclization step using the Heck coupling to form protected Palmerolide A.174 
Scheme 10. Cyclization step using RCM to form protected Palmerolide A.128 
Scheme 11. Palmerolide A: comparison of methods used for formation of the ring. 
In 2014, Kulkenon was prepared by Kalesse.175 A Heck macrocylization, followed by 
deprotection, permitted the synthesis of Kulkenon in 25% yield for the two steps (Scheme 12). 
The Heck reaction afforded an inseparable mixture of isomers that could only be separated after 
deprotection of the two TBS groups. The authors offer no explanation as to the identity of the 
isomers formed during the cyclization. This represents the first total synthesis of Kulkenon and 
permitted the assignment of the correct configuration of this interesting natural product. 
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Scheme 12. Last steps in the total synthesis of Kulkenon. 
Mandelalide A was also prepared using an intramolecular Heck reaction by two different 
research groups in 2014 and 2016 (Scheme 13). Gosh and co-workers achieved a 58% yield in 
the Heck macrocyclization step.176 This allowed them to complete the total synthesis of 
Mandelalide A aglycone. The research group of Smith prepared the natural product macrolide 
using similar conditions achieving a 75% yield in this step.173 They applied the same approach 
to the synthesis of Mandelalide L, an analog of Mandelalide A.  
Scheme 13. Cyclization step to form the proposed structure of Mandelalide A aglycone.176 
In addition, Mandelalide A was also synthesised using a macrolactonization in 2016 by two 
research groups. Ghosh and his co-workers used a Yamaguchi macrolactonization to achieve 
the protected macrolide in 56% yield.23 Altmann’s research group tried to employ Yamaguchi, 
Keck and Corey–Nicolaou macrolactonization protocols but they only obtained traces of 
Mandelalide A. Fortunately, the Shiina conditions allowed them to obtain a 57% yield in the 
cyclization step using high-dilution conditions with 4-fold excess of MNBA and 10-fold excess of 
DMAP.24 However, the double bond conjugated to the carboxylic acid group partially migrated to 
the , position and an isomerization step was needed. Moreover, Mandelalide A was also 
cyclized using a HWE reaction,184 as explained in section 6.5 and a RCAM152,153 (Scheme 14). 
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Scheme 14. Mandelalide A: comparison of methods used for formation of the ring. 
Biselyngbyolide B was also macrocyclized using a Heck reaction in 2016 by Goswami.172 
They studied the optimum reagents needed for this transformation and discovered that a 
combination of Pd(OAc)2/K2CO3/Bu4NCl in DMF afforded the desired macrocycle in 58% yield 
(Scheme 15). 
Scheme 15. Cyclization step to form protected Biselyngbyolide B. 
The same year Ghosh prepared Maltepolide C, a macrolide that was first isolated from the 
fermentation broth of the Myxobacterium Sorangium Cellulosum (Figure 6).171 The 
macrocyclization was achieved in 55% yield over two steps (Scheme 16). 
Figure 6. Structure of Maltepolide C. 
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Scheme 16. Cyclization step to form protected Maltepolide C. 
Pestalotioprolide G was synthesized in 2017 by Goswami.169 The authors chose a Heck 
macrocyclization, instead of the more common macrolactonization approaches for two reasons. 
First, the synthetic route would be more convergent, and second, it would avoid the difficult 
synthesis of the acid functionality at C1 from its corresponding alcohol in presence of a sensitive 
diene moiety. After screening a number of reaction conditions, they only achieved a 25% yield in 
the cyclization. They attributed this low yield to the ring strain which was expected to develop 
during the installation of the diene moiety. This is the first report of the construction of such a 
14-membered ring system using a Heck macrocyclization (Scheme 17). 
Scheme 17. Cyclization step to form Pestalotioprolide G. 
 
6.3. MACROCYCLIZATION VIA SUZUKI COUPLING 
The Suzuki coupling206 is a palladium-catalyzed cross-coupling reaction where an 
organoborane and a vinyl or aryl halide react to give the coupled product under basic 
conditions. This reaction is also called Suzuki–Miyaura coupling, recognizing the efforts of both 
Miyaura and Suzuki in developing the method. However, the reaction is well-known as Suzuki 
coupling. The method provides a good versatile solution to construct a new C–C bond with a 
high tolerance of many functional groups. In addition, the stability to air and moisture of the 
organoboranes involved has turned the reaction into one of the most used cross-couplings in 
organic chemistry. 
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The catalytic cycle of the Suzuki coupling is shown in Scheme 18. To begin with, an 
oxidative addition between the vinyl or aryl halide and palladium takes place. The presence of a 
base gives an intermediate that allows the transmetallation to occur, obtaining a species that is 
transformed into the macrolide by reductive elimination. The first Suzuki macrocyclization used 
in the total synthesis of a macrolide was White’s total synthesis of rutamycin in 1998.207 Since 
then many examples have appeared in the literature,199 although only two in the period 
examined. 
Scheme 18. Proposed catalytic cycle of the Suzuki coupling to form a macrolide. 
In 2014, Prusov and co-workers synthesized 5,6-dihydroripostatin A, a Ripostatin analog, in 
26% yield using an intramolecular Suzuki reaction (Scheme 19).106 In view of the poor yield 
obtained, they tried to use a macrolactonization but were not able to prepare the required seco-
acid. An alternative Suzuki macrocyclization also failed. Fluorinated analogues were then 
prepared using RCM, as in a previous total syntheses,130–133 obtaining, in this case, good yields 
(Scheme 20). 
Scheme 19. Cyclization step to form protected 5,6-dihydroripostatin A. 
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Scheme 20. Ripostatin B: comparison of methods used for formation of the ring. 
The aglycone of Tiacumicin B, also called lipiarmycin A3 or fidaxomicin, is an atypical 
macrolide antibiotic used in the treatment of Clostridium difficile infections. Its total synthesis 
was reported by Glaus and Altmann in 2015 for the first time.178 The ring closure was effected 
using [Pd(PPh3)4], TIOEt and was complete in less than 30 minutes at room temperature 
obtaining a 73% yield (Scheme 21). In addition, Tiacuminicin B was also synthesised the same 
year using RCM in the macrocylization step by Elias Kaufmann and his co-workers.82 Using the 
second generation Grubbs catalyst (20 mol %) a 75% yield was obtained, although as a 2:1 E:Z 
mixture. The Z alkene could be isomerized to the desired E compound. As a result the overall 
yield for the E alkene increased to 63% (Scheme 22). 
Scheme 21. Cyclization step to form protected Tiacumicin B. 
 
Scheme 22. Tiacumicin B: comparison of methods used for formation of the ring. 
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6.4. MACROCYCLIZATION VIA WITTIG REACTION 
The Wittig reaction208 involves the formation of a double bond between an aldehyde or a 
ketone with a triphenyl phosphonium ylide, also called a Wittig reagent. In 1954, George Wittig 
discovered this reaction and became a popular way to synthesize alkenes. Nowadays, it is also 
used to form the ring in organic macrocycles. The Wittig reaction is compatible with most of the 
functional groups but if the aldehyde or ketone is sterically hindered, the reaction may be slow 
and give poor yields. 
In Scheme 23, the Wittig reaction in its intramolecular version to form a macrolide is shown. 
First, nucleophilic addition of the Wittig reagent to the carbonyl gives an intermediate betaine. A 
carbon-carbon bond rotation of this betaine forms an oxaphosphetane that eliminates 
triphenylphosphine oxide to form the macrolide ring. 
 Scheme 23. Wittig reaction to form a macrolide. 
During the period examined only two total syntheses of macrolides using a Wittig 
macrocyclization have appeared in the literature, both by the group of Schobert. In 2014, they 
prepared Chloriolide190 as shown in Scheme 24. The air- and moisture-stable ylide is prepared 
by reaction of an alcohol with Ph3PCCO. Then, they unmask the hemiacetal by acid treatment, 
a process that converts the ylide into the corresponding phosphonium salt. The ylide is then 
regenerated with NaOH and reacts in situ with the aldehyde in equilibrium with the hemiketal, 
forming the desired E-alkene in 65% yield. 
Scheme 24. Cyclization step to form Chloriolide. 
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The same group prepared also Aspicilin in 2017 using a similar strategy (Scheme 25).189 
The reaction temperature had to be controlled to avoid a competitive intramolecular conjugate 
addition between to the ,-unsaturated ester formed in the intramolecular Wittig reaction, 
forming a tetrahydrofuran ring. Running the Wittig reaction at 70 ºC, suppressed the undesired 
conjugate addition and provided aspicillin in 40% yield. Moreover, Aspicilin was also prepared in 
2012 by Hou using RCM conditions with the second generation Grubbs catalyst in 40% yield.141 
Furthermore, this macrolide has also been synthesized using a macrolatonization.60 In 2012, 
Reddy used a Yamaguchi reaction to provide the protected macrolide in 68% yield (over 2 
steps) (Scheme 26). 
Scheme 25. Cyclization step to form protected Aspicilin. 
Scheme 26. Aspicilin: comparison of methods used for formation of the ring. 
 
6.5. MACROCYCLIZATION VIA HORNER-WADSWORTH-EMMONS REACTION 
The Horner–Wadsworth–Emmons olefination (HWE) is the reaction between an aldehyde or 
a ketone with a stabilized phosphonate carboanion that involves the formation of a double bond. 
The HWE reaction shares some characteristics of the Wittig reaction, but as result of the more 
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nucleophilic and less basic properties of phosphonate-stabilized carboanions, the reaction is 
milder and more likely to occur. 
Scheme 27 shows a representation of the HWE reaction for the formation of macrocycles. 
At the beginning, a nucleophilic addition of the carbanion to the aldehyde or ketone produces an 
intermediate that converts into an oxaphosphetane. Finally, elimination of a phosphate 
generates the macrocyclic alkene. 
Scheme 27. HWE reaction to form a macrolide. 
The intramolecular Horner-Wadsworth-Emmons reaction has been a reliable procedure for 
the formation of macrolides since the pioneering studies, in 1979, of Stork and Nakamura209 and 
Nicolaou.210 During the period examined several product macrolides have been cyclized using 
this method. 
For example, the macrocycle of Zampanolide and Dactylolide was successfully synthesized 
using the HWE reaction in 2012 by Altmann in excellent yield (Scheme 28).187 The synthesis of 
side chain-modified zampanolide analogs using the same approach is also described in the 
paper. In addition, Zampanolide was also synthesised in 2012 using RCM by the Ghosh 
research group using the Grubbs II catalyst in 65% yield127 (Scheme 29). 
Scheme 28. Cyclization step to form the core macrocycle of Zampanolide and Dactylolide. 
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Scheme 29. Zampanolide: comparison of methods used for formation of the ring. 
An intramolecular HWE reaction was also used to prepare Mandelalide A in 2014 by the 
research group of Xu and Ye.184 The macrocyle was obtained in 44% yield for two steps 
(Scheme 30). 
Scheme 30. Cyclization step to form protected Mandelalide A. 
In 2013, Nagorny published the total synthesis of Lactimidomycin using a HWE 
cyclization.186 The high ring-strain of this 12-membered unsaturated macrolide complicates the 
preparation of the cycle (Figure 7). The authors chose a HWE reaction to form at the same time 
the ,-unsatured lactone and the ring, thus minimizing manipulation of this sensitive moiety. 
After optimization, a Zn(II)-mediated HWE reaction furnished the desired macrocycle in 93% 
yield. Finally, deprotection and installation of the side chain afforded the final compound 
(Scheme 31). 
Figure 7. Structure of Lactimidomycin. 
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Scheme 31. Cyclization step to form protected Lactimidomycin macrocycle. 
Dias and de Lucca published in 2015 the first total synthesis of Marinisporolide C, a 34-
membered oxopolyene macrolide using an intramolecular HWE reaction.182 The authors initially 
planned to synthesise Marinispolide A, which is a geometrical isomer of Marinispolide C (Figure 
8). Surprisingly, after HWE macrocyclization and global deprotection, they isolated, in 15% 
yield, Marisnispolide C (Scheme 32). When Marinispolide A is exposed to ambient light, an 
equilibrium mixture favoring Marisnispolide C is obtained after 2 h. This seems to indicate that 
Marinispolide C is the thermodynamically most stable isomer. As the authors conducted their 
reactions in the dark, they believe that Marinispolide C was formed due to acid-catalyzed 
isomerization. Two years later, in 2017, a full report of this total synthesis was published.183 In 
this second article, the authors describe that attempts at the total synthesis of the Marinispolides 
using several macrolactonization protocols were unsuccessful, probably due to the presence of 
an -substituent in the ,-unsaturated seco-acid. 
Figure 8. Structures of Marinisporolide A and C. 
Scheme 32. Cyclization step to form protected Marinisporolide C. 
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Brefeldin A was synthesized in 2016 by Raghavan and Yelleni.181 They used the Roush–
Masamune conditions (LiBr, DBU and Et3N) to form the ring in 60% yield (Scheme 33). Finally, 
deprotection of the silyl ethers under acid conditions furnished the final compound. An 
alternative synthesis of Brefeldin A using a Yamaguchi macrolactonization was also described 
in 2016 by Hale in 80% yield22 (Scheme 34). 
Scheme 33. Cyclization step to form protected Brefeldin A. 
Scheme 34. Brefeldin A: comparison of methods used for formation of the ring. 
Two diasteromers of Gliomasolide E were prepared in 2017 by the group of Mohapatra.179 
They also used the Roush–Masamune conditions obtaining a 80% yield in the HWE cyclization 
(Scheme 35). By comparison of the NMR data of the two Gliomasolide E diasteromers with that 
of the natural product, they could assign the absolute stereochemistry of the natural product. 
Scheme 35. Cyclization step to form two protected diasteromers of Gliomasolide E. 
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In 2017, the total synthesis of Neomaclafungin A was published by Wu.180 The formation of 
the ring of this complex molecule worked in only 33% yield (Scheme 36). Nevertheless, after a 
difficult final global deprotection, they could complete the synthesis of the macrolide and 
establish its relative and absolute configuration. 
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7. CONCLUSIONS 
In this work, a bibliographic search has been undertaken to find which macrocyclization 
methods, apart from macrolactonization and ring-closing metathesis, are used nowadays for the 
synthesis of macrolides. Many methods have been identified and five of them have been 
reviewed. Three of these methods were cross-coupling methods and the other two were based 
on the formation of a double bond.  
Analysis of the number of articles per method, we can conclude, as expected, that 
macrolactonization and RCM are still preferred to cyclize macrolides. However, a growth in the 
use of alternative methods is observed, especially for RCAM. Cross-coupling methods are also 
gaining popularity for macrocyclization. Ring-closure of the cycle by formation of a double bond 
(Wittig and HWE) is less used. 
The literature review reveals that it is not straightforward to predict the best approach to 
cyclize a particular structure. Without doubt, macrolactonization is the most general strategy but, 
even though there are many different conditions for this reaction, sometimes a particular 
substrate will not macrolactonize successfully (because of ring strain, instability of the 
substrate...). In these instances, RCM approaches are probably the best alternative if the 
macrolide has a suitable structure. For macrolides with 1,3-dienes, Heck, Suzuki or Stille cross-
couplings can also be used with some confidence. Despite all the benefits that 
macrolactonization and RCM have, alternative methods can be beneficial in some cases, as the 
literature review attests, and afford, in some cases, the same or better yields than classical 
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MNBA 2-methyl-6-nitrobenzoic anhydride 
MOM Methoxymethyl 






RCAM Ring-closing alkyne metathesis 
RCM Ring-closing metathesis 
TAS-F Tris(dimethylamino)sulfonium difluorotrimethylsilicate 
TBDPS tert-Butyldiphenylsilyl 
TBS tert-Butyldimethylsilyl 
TC Thiophene-2-carboxylate 
TEMPO 2,2,6,6-Tetramethylpiperidin-1-oxyl 
TES Triethylsilane 
THF Tetrahydrofuran 
TMEDA Tetramethylethylenediamine 
 
 
